Prodigiosin | 2311

Isolated from Serratia marcescens. Displays antibacterial, anticancer, cytotoxic, immunosuppressive, and antiproliferative activities. Prodigiosin induces apoptosis in hematopoietic cancer cells and cells derived from other human cancers, including gastric and colon with no marked toxicity in nonmalignant cell lines. Also acts as a mTORC1 and mTORC2 complex inhibitor.

Prodigiosin displays antibacterial, anticancer, cytotoxic, immunosuppressive, and antiproliferative activities. Also acts as a mTORC1 and mTORC2 complex inhibitor.

2311 | Prodigiosin DataSheet

Alternate Name/Synonyms: 4-methoxy-5-[(Z)-(5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl]-1H,1′H-2,2′-bipyrrole; NSC 47147; BRN 4526727

Appearance: Dark red solid

Formulation: N/A

CAS Number: 82-89-3

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₀H₂₅N₃O

Molecular Weight: 323.43

Cell-Permeable?: Yes

Purity: ≥95% by HPLC

Solubilities: DMSO or Ethanol

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A mTORC1 and mTORC2 complex inhibitor.

MDL Number: N/A

PubChem CID: 5351169

SMILES: CCCCCC1=C(NC(=C1)C=C2C(=CC(=C3C=CC=N3)N2)OC)C

InChi: InChI=1S/C20H25N3O/c1-4-5-6-8-15-11-16(22-14(15)2)12-19-20(24-3)13-18(23-19)17-9-7-10-21-17/h7,9-13,22-23H,4-6,8H2,1-3H3/b18-17-,19-12-

InChi Key: WKGQSEFBQTWRPT-UUPRNIFOSA-N